Expression of MDM2,P53 and P14ARF in human colon cancer
郭洁,沈志祥,谭诗云,罗和生,李海霞,冯志强,杨军
DOI: https://doi.org/10.3969/j.issn.1009-3079.2002.05.011
2002-01-01
World Chinese Journal of Digestology
Abstract:AIM: To determine the expression of P53, MDM2 and P14ARF in human colon cancer tissues. METHODS: Immunohistochemical staining was used in clinical tissue specimens of 36 cases of human colon adjacent to adenocarcinomas and 28 cases of colon adenomas and 42 cases of colon adenocarcinomas with monoclonal antibodies against human P53, MDM2 and P14ARF. RESULTS: The positive rates of P53, MDM2 and P14ARF in the normal mucosa, adenomos and adenocarcinomas were 0, 25 %, 67 %; 0, 0, 21.4 % and 100 %, 82.1 %, 80.9 % respectively. Expression of P53 and MDM2 in the adenocarciinomas were higher than that in normal mucosa (P < 0.05), and that of P14ARF in adenomas and adenocarcinomas were lower than that in normal mucosa (P<0.05). The positive rates of P53, MDM2 and P14ARF in different grades of colon cancer were 44.4 %, 68.0 %, 87.5 %; 11.1 %, 24.0 %, 25.0 % and 88.9 %, 92 %, 37.5 %, respectively, in which the expression of P14ARF in low-differentiated was less obvious than that in high and moderate differentiated cancinomas of the colon (P<0.05). There was positive correlation between P53 and MDM2 (r=0.8805), and negative correlation between P53 and P14ARF (r=-0.8169). In addition, there was no correlation between MDM2 and P14ARF (r=-0.5475). CONCLUSION: P53, MDM2 and P14ARF are expressed in human colon cancer, which may contribute to the occurrence and development of the cancer. Combined detection of P53, MDM2 and P14ARF may be acted as an assistant marker of colon tumor.